eIF4E Inhibitors and Uses Thereof
Copyright © Targeted News Service 2024
2024-12-03
ALEXANDRIA, Virginia, Dec. 3 -- PIC THERAPEUTICS, INC., Natick, Massachusetts has been assigned a patent (No. US 12157732 B2, initially filed Aug. 25, 2022) developed by Christopher L. Vandeusen, Hopkinton, Massachusetts, for "eIF4E inhibitors and uses thereof." . . .